Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.

40350321

Levy Cynthia, Abouda George F, Bilir Bahri M, Bonder Alan, Bowlus Christopher L, Campos-Varela Isabel, Cazzagon Nora, Chandok Natasha, Cheent Kuldeep, Cortez-Pinto Helena, Demir Münevver, Dill Michael T, Eksteen Bertus, Fenkel Jonathan M, Gilroy Richard, Ko Hin Hin, Jacobson Ira M, Kallis Yiannis, Kugelmas Marcelo, Luketic Velimir, Mangia Alessandra, Montano-Loza Aldo J, Mukhopadhya Ashis, Olveira Antonio, Patel Bhaktasharan C, Pietrangelo Antonello, Pradhan Faruq, Salcedo Magdalena, Shiffman Mitchell L, Sprinzl Kathrin, Swann Rachael, Thorburn Douglas, Thuluvath Paul J, Trivedi Palak J, Turnes Juan, Zein Claudia O, Gomes da Silva Hugo, Jaitly Seema, Miller Benjamin, Milligan Claire, Tavenard Aude, Kowdley Kris V

Journal of hepatology

10.1016/j.jhep.2025.04.025